Results 211 to 220 of about 12,119 (223)

Short Myelitis Lesions in Aquaporin-4-IgG–Positive Neuromyelitis Optica Spectrum Disorders

JAMA Neurology, 2015
Eoin Flanagan, Brian G Weinshenker, Karl N Krecke, Facr   +2 more
exaly  

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

New England Journal of Medicine, 2019
Sean J Pittock, Achim Berthele, Kazuo Fujihara   +2 more
exaly  

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study

Lancet Neurology, The, 2013
Sean J Pittock, Andrew McKeon, Jay Mandrekar   +2 more
exaly  

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2017
Chun-Sheng Yang, Fu-Dong Shi
exaly  

Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations

Nature Reviews Neurology, 2020
Yang Mao-Draayer, Sandra Thiel, Tanuja Chitnis   +2 more
exaly  

Epidemiology of neuromyelitis optica spectrum disorder

Acta Neurologica Scandinavica, 2018
N. Asgari, S. T. Lillevang, H. P. B. Skejoe, M. Falah, E. Stenager, K. O. Kyvik   +5 more
openaire   +3 more sources

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder

JAMA Neurology, 2013
Su-Hyun Kim, So-Young Huh
exaly  

The spectrum of neuromyelitis optica

Lancet Neurology, The, 2007
Dean M Wingerchuk, Sean J Pittock, Brian G Weinshenker   +2 more
exaly  

The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates

Multiple Sclerosis Journal, 2017
Kerry Mutch, Tom Solomon, Anu Jacob
exaly  

Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review

Multiple Sclerosis and Related Disorders, 2019
Rozita Doosti, Seyed Ehsan Mohammadianinejad, Mohammad Ali Sahraian   +2 more
exaly